SCHEMBL289394

SCHEMBL289394

CC(C)(C)CP(C(C)(C)C)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14743059 0.96
Hydrochloric Acid SCHEMBL17491854 0.77
SCHEMBL14742727 0.72
SCHEMBL1767643 0.67
SCHEMBL243119 0.67
SCHEMBL1982617 0.67 TSHR (0.36) TSHRTDP1
SCHEMBL18531908 0.67
SCHEMBL15286085 0.65
SCHEMBL301108 0.64 TSHR (0.33) TSHRTDP1
SCHEMBL10836591 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427468-B2 PREPARATION OF A METAL COMPLEX JOHNSON MATTHEY PLC (GB) 2025-06-04 EP claimed
CN-119019883-A Electrolyte membrane additive, electrolyte membrane and application thereof 国家电投集团科学技术研究院有限公司 2024-11-26 CN claimed
CN-118852046-A Preparation method of stable isotope labeled oxazolidone internal standard reagent 谱同生物医药科技(常州)有限公司 2024-10-29 CN claimed
CN-118307475-A Preparation method of stable isotope labeled fluxapyroxad internal standard reagent 谱同生物医药科技(常州)有限公司 2024-07-09 CN claimed
CN-118090990-A Preparation method of stable isotope labeled hypnone internal standard reagent 谱同生物医药科技(常州)有限公司 2024-05-28 CN claimed
CN-115960051-B Preparation method of stable isotope labeled pyrimethanil internal standard reagent 谱同生物医药科技(常州)有限公司 2023-12-19 CN claimed
EP-4267591-A2 ORGANOMETALLIC COMPOUNDS Umicore AG & Co. KG (DE) 2023-11-01 EP claimed
CN-116802187-A Organometallic compounds 优米科尔股份公司及两合公司 2023-09-22 CN claimed
WO-2022136049-A2 ORGANOMETALLIC COMPOUNDS UMICORE AG & CO. KG (DE) 2022-06-30 WO claimed
EP-2981560-B1 CURING OF LIQUID THERMOSETTING RESINS REICHHOLD LLC 2 (US) 2021-10-13 EP claimed
US-8153794-B2 Catalysts useful for catalyzing the coupling of arylhalides with arylboronic acids E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-04-10 US claimed
US-20100022780-A1 PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2010-01-28 US claimed
EP-2102150-A1 PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-09-23 EP claimed
CN-101541740-A Process for preparing 2-amino-5-cyanobenzoic acid derivatives DU PONT (US) 2009-09-23 CN claimed
US-20090054650-A1 Novel Catalysts Useful for Catalyzing the Coupling of Arylhalides with Arylboronic Acids IONKIN ALEX SERGEY 2009-02-26 US claimed
WO-2008070158-A1 PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-06-12 WO claimed
CN-101031595-A One-component cationic palladium pre-initiator for the latent polymerization of cycloolefins PROMERUS LLC (US) 2007-09-05 CN claimed
US-20060281923-A1 Novel catalysts useful for catalyzing the coupling of arylhalides with arylboronic acids E. I. DU PONT DE NEMOURS AND COMPANY 2006-12-14 US claimed
EP-1680218-A2 SINGLE COMPONENT CATIONIC PALLADIUM PROINITIATORS FOR THE LATENT POLYMERIZATION OF CYCLOOLEFINS Promerus, LLC (US) 2006-07-19 EP claimed
WO-2005042147-A2 SINGLE COMPONENT CATIONIC PALLADIUM PROINITIATORS FOR THE LATENT POLYMERIZATION OF CYCLOOLEFINS PROMERUS, LLC (US) 2005-05-12 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022780-A1 PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES PRMT6, C5, CHRM1 TSHR 1137/4885TDP1 2679/4885
US-20090054650-A1 Novel Catalysts Useful for Catalyzing the Coupling of Arylhalides with Arylboronic Acids DDT, AHR, DDC TSHR 2091/4885TDP1 2735/4885
US-20060281923-A1 Novel catalysts useful for catalyzing the coupling of arylhalides with arylboronic acids DDT, AHR, DDC TSHR 2091/4885TDP1 2735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.